Expert Highlights Shifting Management of Localized Bladder Cancer
Published: Thursday, Mar 19, 2020
John P. Sfakianos, MD
Treatment options for patients with localized bladder cancer, beyond Bacillus Calmette-Guérin (BCG), are evolving as immunotherapies and novel agents are gaining traction in the management of this population, according to John P. Sfakianos, MD.
... to read the full story